Europe — EMA
Olmesartan Medoxomilo Farmoz
Olmesartan medoxomil, the active ingredient in Olmesartan Medoxomilo Farmoz, is a angiotensin II receptor blocker presented as a tablet for oral use. It is employed in the management of hypertension in adult patients.
Request sourcing
What is Olmesartan Medoxomil?
Olmesartan medoxomil, the active ingredient in Olmesartan Medoxomilo Farmoz, is a angiotensin II receptor blocker presented as a tablet for oral use. It is employed in the management of hypertension in adult patients. GNH USA supplies Olmesartan Medoxomilo Farmoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
GNH USA supplies Olmesartan Medoxomilo Farmoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Olmesartan Medoxomil used for?
Olmesartan medoxil is an antihypertensive agent that acts on the renin‑angiotensin system to lower blood pressure.
- Essential hypertension: reduces systolic and diastolic blood pressure and lowers cardiovascular risk. - Diastolic heart failure: assists in afterload reduction and improves cardiac output. - Diabetic nephropathy: slows progression of renal impairment associated with hypertension. - Stroke prevention: contributes to secondary prevention of cerebrovascular events in hypertensive patients. - Chronic kidney disease: aids in blood‑pressure control to protect renal function.
What are the side effects of Olmesartan Medoxomil?
Olmesartan medoxil is generally well‑tolerated, but adverse reactions can occur.
Common Side Effects: - Dizziness - Headache - Fatigue - Nasal congestion - Diarrhea
Serious or Rare Side Effects: - Angio‑ema - Hyperkalemia - Acute kidney injury - Severe hypotension - Liver enzyme elevation (transaminases).
What precautions apply to Olmesartan Medoxomil?
When prescribing Olmesartan medoxil, clinicians should consider several safety aspects.
- Renal function: monitor serum creatinine and eGFR, especially in patients with pre‑existing kidney disease. - Electrolytes: check potassium levels regularly to detect hyper‑kalaemia. - Pregnancy: contraindicated in the second and third trimesters due to fetal toxicity. - Concomitant NSAID use: may blunt antihypertensive effect and increase renal risk. - Elderly patients: start with lower doses and titrate cautiously. - Store at below 25°C: keep in the original packaging.
What does Olmesartan Medoxomil interact with?
Olmesartan medoxil interacts
Major t g t ewline ewline
---
t ewline
""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""
""" """"""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""
""
Product details
Related products

OLMESARTAN MEDOXOMIL 5 mg/1
Olmesartan medoxomil · 5 mg

OLMESARTAN MEDOXOMIL 5 mg/1
Olmesartan medoxomil · 5 mg

OLMESARTAN MEDOXOMIL 20 mg/1
Olmesartan medoxomil · 20 mg

OLMESARTAN MEDOXOMIL 20 mg/1
Olmesartan medoxomil · 20 mg